| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.51B | -2.2% |
| Cost of Revenue | $1.14B | +1.1% |
| Gross Profit | $1.37B | -4.7% |
| R&D Expense | $99.1M | +5.7% |
| SG&A Expense | $1.16B | +9.6% |
| Operating Income | -$1.04B | -3395.9% |
| Pre-tax Income | -$1.08B | -1875.8% |
| Income Tax | $33.9M | -25.2% |
| Net Income | -$1.12B |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.07B | +13.7% |
| Accounts Receivable | $363.0M | -10.9% |
| Inventory | $241.0M | -6.9% |
| Current Assets | $1.79B | +2.6% |
| Total Assets | $5.35B | -19.0% |
| Current Liabilities | $878.7M | +12.5% |
| Long-term Debt | $1.39B | -7.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $336.5M | +22.1% |
| Capital Expenditures | $33.8M | -41.9% |
| Investing Cash Flow | -$54.6M | +12.5% |
| Financing Cash Flow | -$103.7M | -187.2% |
| Free Cash Flow | $302.7M | +39.2% |
| -1016.4% |
| EPS (Basic) | -$6.50 | -983.3% |
| EPS (Diluted) | -$6.50 | -983.3% |
| Stockholders' Equity |
| $2.93B |
| -29.7% |